BRIGhTMIND trial-motivating mechanism of action analysis plan: Magnetic Resonance Spectroscopy
Publication Date
February 10, 2023
Creators
Description
This is the acquired spectra processing and statistical analysis plans for the BRIGhTMIND clinical trial.
It demonstrates hypotheses related with magnetic resonance spectroscopy (MRS) in the BRIGhTMIND and how to test the hypotheses. Detailed information about the BRIGhTMIND can be found in the published protocol paper (Morriss et al., 2020, doi: 10.1136/bmjopen-2020-038430). Imaging acquisition and analysis methods can be found in the magnetic resonance imaging protocol paper (Pszczolkowski et al., 2022, doi: 10.2196/31925).
Subjects
Subjects (JACS)
Subjects (LC)
Divisions
University of Nottingham, UK Campus::Faculty of Medicine and Health Sciences::School of Medicine
Data type
PDF document
Grant Number
EME Project:16/44/22 ACF-2019-12-007
Data collection method
Analysis Plan
Resource languages
English
Publisher
The University of Nottingham
Date Issued
February 10, 2023
Except where otherwise noted, this item's license is described as
File(s)![Thumbnail Image]()
Name
mechanism_of_action_studies_MRS_Final_ver_05Sep23 (2).pdf
Size
325.65 KB
Format
Adobe PDF
Checksum (MD5)
bb2c38817e248177d348a170d6ee3820